Article

Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing

2026-05-27

Abstract excerpt

Epstein-Barr virus (EBV) is an oncogenic virus which is responsible for various malignant as well as non-malignant diseases and leads to about 200,000 deaths each year. Despite efforts, there are no FDA-approved drugs targeting EBV. Reactivation of EBV plays a critical role in the transition from latency to lytic cycle, leading to viral replication and disease progression, and is primarily regulated by the transac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 138ff6fe-5dee-52c9-a827-eeb5d9e6d189
DOI: 10.64898/2026.05.25.727607

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposingDOI 10.64898/2026.05.25.727607Read

Epstein-Barr virus (EBV) reactivation and therapeutic inhibitorsSemantic proximity Read

The Histone Demethylase LSD1/ZNF217/CoREST Complex is a Major Restriction Factor of Epstein-Barr Virus Lytic ReactivationSemantic proximity Read

Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus ReplicationSemantic proximity Read

Bleomycin induced EBV-specific gastric epithelial cell death is enhanced by LMP2ASemantic proximity Read

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSemantic proximity Read

Discovery of Selective Inhibitors Against EBNA1 via High Throughput In Silico Virtual ScreeningSemantic proximity Read

Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.Semantic proximity Read

Update of Natural Products and Their Derivatives Targeting Epstein–Barr InfectionSemantic proximity Read

Divide et Impera: Identification of Small-Molecule Inhibitors of HCMV Replication Interfering with Dimerization of DNA Polymerase Processivity Factor UL44Semantic proximity Read

Design of a First-in-Class homoPROTAC to Induce ICP0 Degradation in Human Herpes Simplex Virus 1Semantic proximity Read

Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 PatientsSemantic proximity Read

MicroRNA-focused CRISPR/Cas9 screen identifies miR-142 as a key regulator of Epstein-Barr virus reactivationSemantic proximity Read